Impact of Vitamin D on Acute Ischemic Stroke Prognosis
IVASTO
1 other identifier
observational
59
2 countries
2
Brief Summary
This is a registry for all patients admitted to hospital settings with Ischemic stroke in Mansoura University Hospital. The registry will capture patients' data, investigations and vitamin D level on admission. Follow-up is taking place using MODIFIED RANKIN SCALE
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2018
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2019
CompletedFirst Posted
Study publicly available on registry
January 28, 2019
CompletedJanuary 28, 2019
January 1, 2019
6 months
January 25, 2019
January 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of Vitamin D level and the Incidence of Ischemic Stroke
Correlation Analyses between vitamin D and ischemic stroke will be applies
On admission
Secondary Outcomes (1)
impact of vitamin D on ischemic stroke in relationship with gender
On admission
Interventions
Vitamin D level is measured upon the presentation of the case with ischemic stroke
Eligibility Criteria
Patients attending to hospital settings diagnosed with ischemic stroke are investigated to have low level of vitamin D
You may qualify if:
- Newly diagnosed ischemic stroke not older than 48 hours
You may not qualify if:
- Ischemic stroke due to accidents or any trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abha International Private Hospitallead
- Mansoura Universitycollaborator
Study Sites (2)
Mansoura University
Al Mansurah, Dakahlia Governorate, Egypt
IQVIA
Basel, 7415, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed FLeifel, MD PhD
Abha International Private Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2019
First Posted
January 28, 2019
Study Start
August 1, 2018
Primary Completion
January 25, 2019
Study Completion
January 25, 2019
Last Updated
January 28, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share
Data of study participants will be kept confidential and no intention for distribution.